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silencing of PU.1 expression in mouse pro–T cells
Hiroyuki Hosokawa1,2,3, Maria Koizumi1, Kaori Masuhara1, Maile Romero-Wolf3, Tomoaki Tanaka4, Toshinori Nakayama5, and
Ellen V. Rothenberg3
PU.1 (encoded by Spi1), an ETS-family transcription factor with many hematopoietic roles, is highly expressed in the earliest
intrathymic T cell progenitors but must be down-regulated during T lineage commitment. The transcription factors Runx1 and
GATA3 have been implicated in this Spi1 repression, but the basis of the timing was unknown. We show that increasing Runx1
and/or GATA3 down-regulates Spi1 expression in pro–T cells, while deletion of these factors after Spi1 down-regulation
reactivates its expression. Leveraging the stage specificities of repression and transcription factor binding revealed an
unconventional but functional site in Spi1 intron 2. Acute Cas9-mediated deletion or disruption of the Runx and GATA motifs
in this element reactivates silenced Spi1 expression in a pro–T cell line, substantially more than disruption of other candidate
elements, and counteracts the repression of Spi1 in primary pro–T cells during commitment. Thus, Runx1 and GATA3 work stage
specifically through an intronic silencing element in mouse Spi1 to control strength and maintenance of Spi1 repression
during T lineage commitment.
Introduction
PU.1, encoded by Spi1, is an E twenty-six (ETS)–family tran-
scription factor with multiple roles in the development and
function of myeloid and lymphoid hematopoietic lineages
(Carotta et al., 2010; Rothenberg et al., 2019; Singh et al., 1999).
Expression levels of Spi1 are highest in macrophages, gran-
ulocytes, and dendritic cells and moderate in lymphoid pro-
genitors, reducing expression in B cells and turning off entirely
in natural killer and T cells (Yoshida et al., 2019). Through
pioneering-like activity and differential cofactor recruitment,
PU.1 can control specification of several blood cell types (Heinz
et al., 2010; Heinz et al., 2013; Hosokawa et al., 2018b; Ostuni
et al., 2013; Rothenberg et al., 2019). Dysregulation of Spi1 ex-
pression and translocation of the Spi1 gene can induce malignant
transformation in multiple hematopoietic lineages (Rosenbauer
et al., 2004; Seki et al., 2017; Vangala et al., 2003). Thus, Spi1
expression must be tightly regulated in a lineage-specific man-
ner. Spi1-deficient hematopoietic stem cells fail to contribute to
the T cell lineage in bone marrow (BM) chimera mice (Dakic
et al., 2005; Scott et al., 1994), but Spi1 expression must be shut
off during T lineage commitment. The mechanism of this re-
pression has remained obscure until now.
T cells develop from multipotent precursors in the thymus,
where microenvironmental Notch signaling educates progeni-
tors to become T cells (Hosokawa and Rothenberg, 2021; Radtke
et al., 2013; Romero-Wolf et al., 2020). The earliest T progenitors
in the thymus lack expression of the mature T cell markers CD4
andCD8 (double negative [DN]). The expression profiles of Kit, CD44,
and CD25 in DN thymocytes distinguish developmental stages
(Hosokawa et al., 2021; Hosokawa and Rothenberg, 2021; Rothenberg
et al., 2008; Yang et al., 2010; Yui and Rothenberg, 2014). The earliest
T cell precursors in the thymus, Kithi DN1 cells (here “DN1,”
Kithi+CD44+CD25−, or ETP), and their DN2a (Kithi+CD44+CD25+) de-
scendants, still have access to non–T cell fates and proliferate to ex-
pand the intrathymic progenitor pool (Lu et al., 2005). They lose
multipotency in transition from DN2a to DN2b (Kitint+CD44+CD25+),
becoming committed to the T lineage (Fig. 1 A). Next, TCRβ gene
rearrangement at the DN3 (KitloCD44loCD25+) stage triggers pre-
TCR–dependent progression to DN4 (KitloCD44loCD25−) and double-
positive (CD4+CD8+) stages, leading to full TCR expression (Hosokawa
and Rothenberg, 2018; Yui and Rothenberg, 2014).
The chromatin landscape and transcriptome profiles change
dynamically at the transition from precommitment, DN1 and
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DN2a, pro–T cells to T lineage–committed, DN2b and DN3,
pro–T cells (Hosokawa et al., 2021; Hosokawa and Rothenberg,
2021; Hu et al., 2018). Two transcription factors, PU.1 and Bcl11b,
change expression reciprocally in this process.While Bcl11b turns
on as cells undergo commitment (Kueh et al., 2016; Zhou et al.,
2019), Spi1 is shut off during T lineage commitment, eliminating
access to myeloid programs (Hosokawa et al., 2021; Hosokawa
and Rothenberg, 2018; Yui and Rothenberg, 2014; Fig. 1 A).
Conditional deletion of the Spi1 gene before commitment not
only causes faster developmental progression but also reduces
cell yield (Champhekar et al., 2015; Hosokawa et al., 2018b).
Thus, PU.1 supports the expansion of the uncommitted DN1 and
DN2a T progenitor pool (Hosokawa and Rothenberg, 2021).
However, inefficient repression or abnormal activation of Spi1
after T lineage commitment can yield malignancy, directly or via
its target genes (Boehm et al., 1991; Homminga et al., 2011;
Hosokawa and Rothenberg, 2021; Rosenbauer et al., 2006; Seki
et al., 2017; Yui and Rothenberg, 2014).
Regulatory mechanisms controlling Spi1 expression kinetics
during early T cell development are not fully understood. Mul-
tiple reports have suggested roles for Runx1 and GATA3 as
mediators of Spi1 repression in mouse pro–T cells. When Runx1
was deleted conditionally by Mx1-Cre activation in mice, early
T cell development was significantly blocked at precommitment
stages with increased Spi1 expression (Growney et al., 2005;
Huang et al., 2008), and Runx1 deletion in pro–T cells developing
in vitro also caused Spi1 up-regulation (Hosokawa et al., 2018b).
GATA3 overexpression severely repressed Spi1 in fetal pro–
T cells (Taghon et al., 2007), while shRNA knockdown of Gata3
caused up-regulation of Spi1 in fetal thymus- or liver-derived
pro–T cells (Scripture-Adams et al., 2014). However, Runx1 and
Gata3 perturbation in progenitor cells also strongly reduces
pro–T cell yields, and their expression increases little during
commitment. Thus, how Runx1 and GATA3 cause this stage-
specific Spi1 repression has remained uncertain.
Multiple cis-regulatory elements around the Spi1 locus could
play roles. The promoter, a major upstream regulatory element
(URE), and conserved noncoding element 4 (CE4) and CE5 have
all been suspected to play roles in cell type–specific regulation of
Spi1 in myeloid, B, and T cells (Hoogenkamp et al., 2007; Li et al.,
2001; Okuno et al., 2005; Rosenbauer et al., 2006; Rosenbauer
et al., 2004; Zarnegar et al., 2010). The URE, a highly conserved
noncoding genomic region 14 kb upstream of the transcriptional
start site of Spi1 (−14 kb; Li et al., 2001; Okuno et al., 2005),
showed enhancer activity in myeloid and B cells (Rosenbauer
et al., 2006; Rosenbauer et al., 2004), while its T lineage role
appeared bivalent or repressive (Hoogenkamp et al., 2007;
Huang et al., 2008; Montecino-Rodriguez et al., 2018; Zarnegar
et al., 2010). URE KOmice showed a partial defect in early T cell
development, characterized by increased Spi1 expression in DN1
as well as DN3 stages of adult mice (Rosenbauer et al., 2006).
Thus, the bifunctional URE region can damp Spi1 expression in
pro–T cells, but whether it explains the switch to repression is
less clear. CE4 and CE5, upstream (−9.2 and −10.3 kb) conserved
noncoding regions, were identified as T cell–specific silencer
and myeloid-specific enhancer elements using reporter assays
with cell lines (Zarnegar et al., 2010). However, CE4 element
function has not been demonstrated in its native context.
Here, we describe a new regulatory element through which
GATA3 and Runx1 appear to work stage specifically to silence
Spi1 in T lineage commitment. Using pro–T cell differentiation
cultures with acute, stage-specific perturbations, we verify roles
and structural requirements of GATA3 and Runx1 for Spi1 re-
pression. Highly stage-specific binding of Runx1 and GATA3 in
Figure 1. Expression profiles of GATA3, PU.1, and Bcl11b around the T
lineage commitment checkpoint. (A) Schematic of early T cell development
is shown with expression kinetics of the transcription factors Spi1 (PU.1),
Runx1, Gata3, and Bcl11b. (B) Intracellular staining for GATA3 and PU.1 was
performed using DN thymocytes from Bcl11b-YFP reporter mice, gated as in
Fig. S1 A. Representative profiles of isotype control (left), GATA3 (middle),
and PU.1 (right) with Bcl11b-YFP in DN1, DN2a, and DN2b are shown with the
percentages of cells in each quadrant. Results are representative of three
independent experiments. (C) Intracellular staining profiles of GATA3 (left)
and PU.1 (right) in DN1, DN2a-YFP−, DN2a-YFP+, and DN2b are shown. The
gray-filled histogram shows isotype control staining. GATA3, DN2a YFP+ and
DN2b curves overlap; PU.1, DN1 and DN2a YFP− curves overlap. Results are
representative of three independent experiments.
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pro–T cells during commitment identifies a Spi1 intronic site that
is functionally important for the magnitude and maintenance of
Spi1 repression in a pro–T cell line and primary pro–T cells, with
greater impact than CE4 or other candidate repression elements.
Taken together, this evidence identifies a direct mechanism
through which Runx1 and GATA3 mediate the stage-specific
repression of Spi1.
Results
Runx1 and GATA3 protein expression relative to Spi1
expression around T lineage commitment
Gata3 turns on soon after precursors enter the thymus, reaching
a plateau in late DN2a stage (Yoshida et al., 2019; Zhou et al.,
2019; Fig. 1 A). Pro–T cells express Runx1more highly than other
hematopoietic cell types (Yoshida et al., 2019), and both Runx1
mRNA and protein are highest across commitment (Shin et al.,
2021; Zhou et al., 2019). In DN pro–T cells, shortly before Spi1
expression decreases, expression of Gata3 and Runx1 mRNA in-
creases slightly (Yoshida et al., 2019; Zhang et al., 2012).
To determine whether GATA3 protein levels could be rate
limiting for PU.1 silencing in early pro–T cells, we conducted
intracellular staining for GATA3 and PU.1. We used thymocytes
from Bcl11b-YFP reporter mice (Kueh et al., 2016) to monitor
Bcl11b up-regulation, marking T lineage commitment in late
DN2a stage (Fig. 1 A), and compared DN1 (Kithi+CD25−), DN2a
(Kithi+CD25+), and DN2b (Kitint+CD25+) stages among the DN,
Lin−CD44+Kit+ thymocytes (Fig. S1 A). The results (Fig. 1, B and
C) confirmed that GATA3 levels were very low in the DN1 stage,
slightly up-regulated in the DN2a Bcl11b− (YFP−) stage, and
further increased in the DN2a Bcl11b+ (YFP+) and DN2b stages.
PU.1 was highly expressed in the DN1 and DN2a Bcl11b− stages
but then shifted lower in DN2a cells as they began to express
Bcl11b (Fig. 1, B and C) and had clearly dropped by DN2b stage
(cf. Ungerbäck et al., 2018; Yui et al., 2010). Given the high
protein stability of PU.1 (Kueh et al., 2013), the slight reduction
seen in Bcl11b+ DN2a cells is consistent with the onset of re-
pression. In separate work (Shin et al., 2021), we found that
Runx1 protein also detectably increased from the DN1 to DN2a/b
stages. Thus, GATA3 and Runx1 protein levels beyond a certain
threshold could influence the timing of PU.1 repression.
Transduction of Runx1 and Gata3 represses Spi1 expression in
precommitment pro–T cells
To verify whether Runx1 and/or GATA3 levels control Spi1 ex-
pression in pro–T cells, we tested whether their overexpression
in DN1 and DN2a pro–T cells could accelerate the natural si-
lencing of Spi1. Runx and GATA3 perturbations are demonstrably
toxic in vitro, leaving some uncertainty as to whether gene-
expression changes seen in previous studies reflected direct
gene regulation or population selection (Guo et al., 2008; Huang
et al., 2008; Scripture-Adams et al., 2014; Taghon et al., 2007;
Telfer et al., 2004). We used BM progenitor cells from Bcl2
transgenic (Tg) mice to maximize viable recovery, culturing
them on OP9 Delta-like 1 (DLL1; a Notch ligand) stroma to initiate
T cell development in vitro (see Materials and methods). On day
3 of culture, when most of the cells were still in precommitment
stages (DN1 and DN2a), they were infected with retroviral vec-
tors expressing Runx1 and/or Gata3 with GFP or human nerve
growth factor receptor (hNGFR) markers, respectively. We sor-
ted Lin−CD45+CD44+GFP+hNGFR+ precommitment cells for
analysis at 3 d postinfection (dpi; day 6 of culture overall; Fig. 2,
A and B; and Fig. S1 B; protocol A). Introduction of Gata3 into
these precommitment cells, which still had high Spi1 expression,
profoundly repressed Spi1, while Runx1 transduction had a
moderate but consistent effect. The combination of Runx1 and
Gata3 introduction further intensified repression of Spi1 (Fig. 2
C). In contrast, while Spi1 down-regulation coincided most
closely with the timing of Bcl11b-YFP activation during devel-
opment, overexpression of Bcl11b did not repress Spi1 expression
(Fig. S1 C). This supports previous indications that Bcl11b does
not itself regulate Spi1 in mouse pro–T cells (Hosokawa et al.,
2018a; Longabaugh et al., 2017).
Antisense transcripts from intron 3 of the Spi1 locus report-
edly act as negative modulators of Spi1 expression (Ebralidze
et al., 2008). Runx1 and GATA3 might reduce Spi1 expression
by stimulating expression of these antisense transcripts. How-
ever, precommitment cells with and without overexpression of
Runx1 and/or Gata3 had comparable ratios of sense and antisense
transcripts of exon3 of the Spi1 gene (Fig. S1 D). Therefore, Spi1
repression by Runx1 and GATA3 does not appear to be mediated
by up-regulation of antisense transcripts of Spi1 locus.
Structural requirements for GATA3 and Runx1 repression
of Spi1
To test whether GATA3 might repress Spi1 directly or whether it
worked by inducing other repressors, we tested GATA3 mutants
that can differentially affect function, localization, and organi-
zation of GATA3 complexes in type 2 T helper and type 2 innate
lymphoid cells (Furusawa et al., 2013; Hosokawa et al., 2015;
Hosokawa et al., 2016; Hosokawa et al., 2013a; Hosokawa et al.,
2013b; Yamagata et al., 2000). Phosphorylation of GATA3 at
S308, T315, and S316 inhibits its repressive action by dissociat-
ing histone deacetylase 2 (HDAC2) from the GATA3–nucleosome
remodeling and deacetylase (NuRD) complex (Hosokawa et al.,
2016; Hosokawa et al., 2013b) and can be mimicked by a triple
phospho-mimetic mutant (GATA3 3D). Transcriptional activity
of GATA3, in contrast, associates with methylation of R261
(Hosokawa et al., 2015). Here, whereas phospho-deficient
(GATA3 3A), methylation-mimicking (GATA3 R261F) and
methylation-deficient (GATA3 R261K) mutants (Hosokawa
et al., 2015; Hosokawa et al., 2016) all repressed Spi1 simi-
larly to GATA3 WT in precommitment, primary pro–T cells,
the GATA3 3D mutant caused only minimal Spi1 repression
(Fig. 2 D). This suggests that unphosphorylated GATA3 itself is
directly involved in the repression mechanism.
Intact Runx1 was also needed to maintain repression, at least
in the Scid.adh.2c2 line, a postcommitment pro–T cell that
normally does not express Spi1 (Dionne et al., 2005; Hosokawa
et al., 2018b). A strongly DNA-binding, truncated form of Runx
(Runx1DN) lacking transactivation and repression domains
competitively blocks both repression (Telfer et al., 2004) and
activation (Hosokawa et al., 2018b) by endogenous Runx factors.
Overexpression of full-length Runx1 in Scid.adh.2c2 cells did not
Hosokawa et al. Journal of Experimental Medicine 3 of 16
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alter the fully silent state of Spi1. However, introduction of the
Runx1DN mutant caused endogenous Spi1 to become activated,
disrupting the established silent state (Fig. 2 E). Thus, the ability
of Runx1 to recruit other protein partners via non-DNA-binding
domains is crucial for maintenance of Spi1 repression.
To identify the functional components of GATA3 complexes
that control PU.1 repression in pro–T stages, we transduced
Scid.adh.2c2 cells with Myc- and Flag-tagged GATA3 and re-
covered GATA3 complexes by two-step affinity purification
followed by SDS-PAGE and silver staining (Fig. S1 E). Analysis by
liquid chromatography and tandem mass spectrometry identi-
fied more than 150 molecules annotated as being involved in
transcription or chromatin remodeling (Fig. S1 F and Table S1,
sheet 1). While multiple subunits for the NuRD and BRG1-
assocated factor (BAF) complexes were repeatedly detected,
Runx1 had one of the highest signals in our mass spectrometry
analyses, consistently in four separate samples (Table S1, sheet
2). The association between GATA3 and Runx1 was validated
by coimmunoprecipitation with immunoblotting. Notably, even
the GATA3 3D mutant (Fig. 2 D) was fully able to interact with
Runx1, similarly to GATA3 WT and 3A mutant (Fig. S1 G), in-
dicating that altered GATA3 activity itself caused by the 3D
mutation accounted for its loss of repressive activity for Spi1.
Stage-specific deletion of Runx1 and Gata3 derepresses Spi1 in
committed pro–T cells
To confirm the role of natural levels of Runx1 and GATA3 ex-
pression in Spi1 repression, we performed acute, stage-specific
Runx1 and Gata3 disruption in primary cells after T lineage
commitment using bicistronic retroviral vectors carrying
sgRunx1 or sgGATA3with CFP or hNGFRmarkers, respectively.
These constructs induced acute, specific losses of the targeted
proteins as detected by immunoblotting when transduced into
Cas9-expressing Scid.adh.2c2 cells (Fig. S2 A). To test their
impact in primary cells, BM progenitor cells from Cas9;Bcl2 Tg
mice were co-cultured on OP9-DLL1 for 10 d, until nearly all
cells had undergone commitment, and then theywere transduced
with the single guide RNA (sgRNA) against Runx1 and/or Gata3,
using control sgRNA transductions for comparison (Fig. 3, A
and B; protocol B). 4-dpi, doubly transduced, postcommitment
Figure 2. Introduction of Runx1 and Gata3 represses Spi1 expression in precommitment stages. (A) An experimental scheme for introduction of Runx1
and/or Gata3 in precommitment pro–T cells is shown (protocol A). (B) BM progenitors obtained from Bcl2 Tg mice were co-cultured on OP9-DLL1. Flow
cytometric analysis of T progenitors was performed on day 3, before retrovirus infection. A representative CD44/CD25 profile in Lin−CD45+ cells is shown (left).
Schematic of the pro–T cell development trajectory is shown (right). Results are representative of three independent experiments. (C) Retrovirus-infected
Lin−CD45+CD44+GFP+hNGFR+ precommitment cells were sorted at 3 d after introduction. Expression levels of Spi1 (left), Runx1 (middle), and Gata3 (right) were
analyzed by RT-qPCR. The relative expression (/Actb) is shown with SD. **, P < 0.01 by two-sided Student’s t test. Data are representative of two independent
experiments and based on three biological replicates. (D) Precommitment cells were introduced with GATA3 WT, phospho-deficient (3A), phospho-mimic (3D;
Hosokawa et al., 2016; Hosokawa et al., 2013b), methylation-deficient (R261K), or methylation-mimic (R261F) GATA3 mutants (Hosokawa et al., 2015;
Nakayama et al., 2017) as protocol A. Expression levels of Spi1 (left) and Gata3 (right) were analyzed by RT-qPCR on 3 d after introduction. The relative
expression (/Actb) is shown with SD. **, P < 0.01 by two-sided Student’s t test. Data are representative of two independent experiments and based on four
biological replicates. (E) Reads per kilobase per million reads (RPKM) values for Spi1 in WT or DN form of Runx1 introduced DN3-like cell lines are shown with
SD (Hosokawa et al., 2018b).
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Lin−CD45+CD44loCD25+CFP+hNGFR+ cells were sorted (Fig. S2
B), followed by RT quantitative PCR (RT-qPCR) analysis for Spi1
mRNA (Fig. 3 C). Expression of Spi1, which is normally low in
these committed cells, was substantially up-regulated by Runx1
or Gata3 KO, and combined loss of Runx1 and Gata3 up-regulated
Spi1 even more (Fig. 3 C). Earlier Runx1 and Gata3 deletion,
around the time of T lineage commitment, had a similar effect.
The deletion was initiated at day 4 (before T lineage commit-
ment) and harvested on day 8 overall (Fig. 3 D; protocol C), in
transition from DN2a to DN2b/DN3 (Fig. S2 C). Again, mRNA
levels of Spi1 were clearly higher in Runx1 and/or Gata3 KO cells
than in controls. This up-regulation was specific for Spi1, be-
cause Bcl11b, a positive target of GATA3 and Runx1 (Kueh et al.,
2016), showed the opposite pattern (Fig. 3 E). Thus, normal
endogenous Runx1 and GATA3 are important for both estab-
lishing and maintaining repression of Spi1 in the T cell lineage
commitment transition.
DN2b/3 stage-specific binding of Runx1 and GATA3 at the
intronic region of the Spi1 locus
Multiple cis-regulatory elements have been described around
the Spi1 locus, especially evolutionarily conserved open chro-
matin regions, that reportedly control levels of Spi1 expression in
various hematopoietic cell types, as discussed in the Introduc-
tion. In an unbiased search for genomic sites that could mediate
active imposition of repression during commitment, we
Figure 3. Deletion of Runx1 and Gata3 induces derepression of Spi1 expression in T lineage–committed cells. (A) BM progenitors obtained from Cas9;
Bcl2 Tgmice were co-cultured on OP9-DLL1 for 10 d. Postcommitment cells were retrovirally introduced sgRNAs against Runx1 and/or Gata3 and then analyzed
4 dpi (protocol B). (B) Flow cytometric analysis of BM-derived pro–T cells was performed on day 10, before sgRNA introduction. A representative CD44/CD25
profile in Lin−CD45+ cells is shown. The result is representative of three independent experiments. (C) sgRNA-introduced Lin−CD45+CD25+CD44loCFP+hNGFR+
postcommitment cells were sorted and subjected to RT-qPCR analysis at 4 d after sgRNA introduction. The relative expression (/Actb) of Spi1 is shown with SD.
**, P < 0.01 by two-sided Student’s t test. Data are representative of two independent experiments and based on three biological replicates. (D) BM pro-
genitors were co-cultured on OP9-DLL1 for 4 d. Precommitment cells were retrovirally introduced sgRNAs against Runx1 and/or Gata3 and then analyzed 4 dpi
(protocol C). (E) sgRNA-introduced Lin−CD45+CFP+hNGFR+ cells (D) were sorted and subjected to RT-qPCR analysis. The relative expression (/Actb) of Spi1 and
Bcl11b is shown with SD. **, P < 0.01 by two-sided Student’s t test. Data are representative of two independent experiments and based on three biological
replicates.
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examined Runx1 and GATA3 binding around Spi1 by chromatin
immunoprecipitation (ChIP) and deep sequencing (ChIP-seq).
We compared their occupancy patterns before (DN1) and after
(DN2b/3) T lineage commitment (Hosokawa et al., 2018b; Fig. 4
A) and compared these with sites changing chromatin acces-
sibility (Yoshida et al., 2019) and looping interactions (Hu et al.,
2018) around Spi1 in pre- and postcommitment pro–T cells (Fig.
S3, A and B). Despite the strong impact of endogenous GATA3
on Spi1, conventional ChIP-seq conditions using formaldehyde
(FA) crosslinking showed little, if any, GATA3 binding near this
locus (Fig. S3 A). However, using a di(N-succinimidyl) gluta-
rate (DSG) cross-linker that stabilizes Runx1-containing
complexes (Hosokawa et al., 2020; Hosokawa et al., 2018b),
GATA3 recruitment was clear (Fig. 4 A; see Materials and
methods). Runx1 and GATA3 were found at URE, CE4 (Huang
et al., 2008; Zarnegar et al., 2010), and the transcriptional start
site of the neighboring Slc39a13 gene. However, none of these
peaks appeared after commitment (Fig. 4 A, blue rectangles). A
site at −17.8 kb previously reported to mediate repression by
GATA1 in erythroid cells (Chou et al., 2009) showed slight
binding, but only in DN1 cells, not DN2b/3 cells.
Notably, however, we saw a small but reproducible peak of
Runx1 and GATA3 association at +3.7 kb within intron 2 of Spi1,
and these signals were highly DN2b/3-stage specific (Fig. 4 A,
Figure 4. Identification of the DN2b/3-specific Runx1 and GATA3 binding site at the Spi1 locus. (A) BM progenitors obtained from B6 mice were co-
cultured on OP9-DLL1 for 5 or 14 d. Lin−CD45+CD25−Kithi+CD44+ DN1 cells and Lin−CD45+CD25+KitloCD44lo DN2b/3 cells were sorted on days 5 and 14,
respectively, and subjected to ChIP-seq analysis for Runx1 (Hosokawa et al., 2018b) and GATA3. Representative ChIP-seq tracks in DN1 and DN2b/3 cells
around the Spi1 locus are shown with the conservation track. Previously reported cis-regulatory elements and a DN2b/3-specific Runx1 and GATA3 binding site
are labeled with blue and magenta rectangles, respectively. Data are representative of two independent experiments. Chr2, chromosome 2. (B) Representative
ATAC-sequencing tracks in DN1, DN2a, DN2b and DN3 cells around the Spi1 locus are shown (Yoshida et al., 2019). (C) The short interspersed nuclear element
(SINE) and LINE element tracks around the Spi1 locus in mouse (mm10) are shown with the conservation track. A position for the DN2b/3-specific Runx1 and
GATA3 binding site is labeled with a magenta rectangle.
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magenta rectangle). Runx1 and GATA3 were also detected here
in Scid.adh.2c2 cells (Fig. S3 C). Despite the modest signals, this
site was the only one in the gene-to-gene interval containing Spi1
(Slc39a13-Mybpc3) that showed DN2b/DN3-specific occupancy by
Runx1 or GATA3. The sequence of this region included multiple
Runx motifs and a GATA motif (see below). Runx1, at least,
appeared to bind to this site independently of GATA3, as shown
by acute knockouts and ChIP-qPCR assays (Fig. S4 A).
Interestingly, this site would not have been identified by
assay of transposase-accessible chromatin (ATAC) accessibility
or conservation. The URE and CE4 regions are ATAC accessible
in DN1 stage and gradually close during pro–T progression, and a
neighboring intron 2 site (at +5.0 kb) appears constitutively
open. But the +3.7-kb site of the Spi1 locus appears “closed” both
before and after commitment (Yoshida et al., 2019; Fig. 4 B,
magenta rectangle). This region also falls within a long inter-
spersed nuclear element (LINE element; Fig. 4 C, magenta
rectangle). Still, this site was close to the intron 2 anchor for a
chromatin looping interaction that appears newly during com-
mitment (Fig. S3 B, dark blue star).
Potential silencer activity of the DN2b/3-specific Runx1 and
GATA3 binding site in the Spi1 locus
To test whether the DN2b/3-specific Runx1 and GATA3 binding
site at +3.7 kb of the Spi1 locus could actually mediate Runx1- and
GATA3-dependent silencer activity, we designed sgRNAs to
disrupt the DN2b/3-specific Runx1 and GATA3 occupancy region
and tested their impact first in the Scid.adh.2c2 pro–T cell line.
Scid.adh.2c2 cells expressing Cas9-GFP were retrovirally trans-
duced in parallel with pairs of sgRNAs flanking each of four
different Runx1 and GATA3 binding regions around the Spi1 lo-
cus. Besides the +3.7-kb region, we targeted the URE, CE4, and
the neighboring Slc39a13 promoter (Slc39a13 pro.). Cas9+ doubly
transduced (GFP+ CFP+ hNGFR+) cells were cloned by single-cell
sorting (Fig. 5 A), and we identified clones with complete loss of
the targeted genomic regions by genomic qPCR analysis (Fig. 5
B). Deletion of 567 bp of the +3.7-kb site (sgInt.2) induced
markedly up-regulated Spi1 expression in Scid.adh.2c2 cells
(Fig. 5 C). In contrast, expression levels of Spi1 were comparable
among cells transduced with sgControl (sgRNA against lucifer-
ase), sgSlc39a13 promoter, and sgURE, whereas disruption of
CE4 (sgCE4) led to only a slight increase in Spi1 expression (Fig. 5
C). Therefore, in this DN3-like cell line, the DN2b/3-specific
Runx1 and GATA3 binding site at +3.7 kb of the Spi1 locus was
required to maintain repression of Spi1.
Because GATA3 binding to the +3.7-kb element seemed weak,
we examined the wider Spi1 locus neighborhood for any addi-
tional sites where GATA3 binding increased from DN1 to DN2b/3.
Of special interest were potential downstream anchor sites for
the commitment-associated looping noted above (Fig. S3 B).
Indeed, elements at +145 kb and +211 kb showed higher GATA3
binding signals in DN2b/3 stages than DN1 (Fig. S4 B), and
another strong GATA3 peak near the potential loop anchor was
seen at +167 kb. All three showed Runx1 and GATA3 co-
occupancy in postcommitment cells with various degrees of
stage specificity. In direct tests, disruption of the +145-kb ge-
nomic region induced weak but reproducible derepression of
Spi1 in Scid.adh.2c2 clones (Fig. S4, C and D), similar to CE4
disruption, whereas disruption of the +167-kb and +211-kb el-
ements had no effect. Therefore, Runx1 and GATA3 may be
involved in establishment of stage-specific repressive chro-
matin looping architectures around the Spi1 locus, including the
+3.7-kb, +145-kb, and CE4 elements.
Roles of Runx and GATA motifs in the DN2b/3-specific Runx1
and GATA3 binding site in PU.1 repression in primary
pro–T cells
In primary pro–T cells, clones could not be grown out and se-
lected for deletion of the complete element, but a Cas9-mediated
point mutation strategy could be highly effective to test the role
of the +3.7-kb element. There are three Runx motifs and one
GATA motif around the center of the +3.7-kb element (Figs. 6 A
and S5 A). Thus, we induced direct mutations in these Runx and
GATA motifs at the +3.7-kb element in primary Cas9;Bcl2 Tg
pro–T cells. Cells were cultured and transduced according to
protocol B using sgRNAs targeting each motif (Fig. 6 A, red ar-
rowheads) and analyzing the postcommitment, multiply trans-
duced cells at day 14 overall (Fig. S5 B). Disruption of individual
motifs had significant but minor effects on Spi1 expression. In
contrast, transduction of the mixture of sgRNAs against all four
motifs induced prominent derepression of Spi1 (Fig. 6 B), albeit not
to full precommitment expression levels. PU.1 protein levels in in-
dividual cells were up-regulated throughout the population when
all four motifs were disrupted (Fig. 6 C), while the cells introduced
with the sgRNA mixture had individually undergone different
combinations of point mutations or small deletions (Fig. S5 C).
Next, we tested whether the activity mediated by the +3.7-kb
element is generally damping or stage specific. We disrupted all
four Runx and GATA motifs early in the culture and then
compared effects on Spi1 levels expressed in precommitment
stages (6 d) and later in postcommitment stages (12 d; Fig. 6 D;
protocol D). Disruption with the four sgRNAs did not affect
progression of DN stages, defined by CD44 and CD25 expression,
and Spi1 showed some developmental down-regulation in com-
mitment in both experimental samples and controls (Fig. S5, D
and E). However, the high expression of Spi1 at 6 dpi (mostly
DN2a/2b) was very similar in control and experimental samples,
whereas by postcommitment stages at 12 dpi (DN2b/3, day 14 of
overall culture), the four sgRNAs substantially alleviated Spi1
repression compared with controls (Fig. 6 E). Thus, the intronic
site of postcommitment stage-specific Runx1 and GATA3 bind-
ing was needed to strengthen or maintain repression of Spi1
expression, stage specifically, after commitment.
Finally, to determine whether the +3.7-kb site was required
to mediate repressive action of Runx1 or GATA3 on Spi1, we
disrupted the four motifs in precommitment pro–T cells and
then transduced the cells with Runx1 or Gata3 (Fig. 7 A; protocol
E). Runx1- and GATA3-mediated repression of Spi1 expression
was significantly weakened in the cells transduced with the
mixed sg4 motifs compared with controls (Fig. 7 B). Although
introduction of Gata3 was still able to cause some repression of
Spi1, the attenuation of this effect via a single intronic element
was notable considering not only the intact +145-kb and CE4
elements but also the multiple potent gene network impacts of
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Runx1 and GATA3 on other regulators in the cells (Scripture-
Adams et al., 2014; Shin et al., 2021; Fig. 7 B). Taken together,
postcommitment stage-specific binding of Runx1 and GATA3 to
the +3.7-kb element of the Spi1 locus may play a substantial role
in timing of Spi1 repression during early T cell development.
Discussion
PU.1 has an indispensable role for the earliest T lineage pre-
cursors in the thymus (Champhekar et al., 2015; Dakic et al.,
2005), but its expression must be shut off during T lineage
commitment, at the transition from DN2a to DN2b, and both the
mechanism and coordination of this timing have needed ex-
planation. Despite evidence that Runx1 and GATA3 play roles in
the repression of Spi1 in pro–T cells, possibly via the URE and
other cis-regulatory elements around the Spi1 locus (Huang
et al., 2008; Rosenbauer et al., 2006; Scripture-Adams et al.,
2014; Zarnegar et al., 2010), both Runx1 and GATA3 are ex-
pressed for many cell divisions before Spi1 is silenced. Similarly,
the chromatin accessibility and transcription factor binding
dynamics at these previously reported genomic elements have
failed to explain how Spi1 expression is repressed specifically
during pro–T cell lineage commitment. This problem motivated
our search for new Runx1–GATA3–Spi1 interactions that could
mediate this stage-specific functional change. Here, we ex-
ploited CRISPR-Cas9–mediated acute, stage-specific deletions of
Runx1, Gata3, and/or potential cis-regulatory elements in an
in vitro T cell development culture system. We confirmed that
precommitment overexpression of Runx1 and GATA3 markedly
accelerated Spi1 repression, whereas stage-specific deletion of
Runx1 and Gata3 derepressed or significantly weakened repres-
sion of Spi1. Using stage-specific Runx1 and GATA3 binding as a
search criterion, we identified a novel element in the second
intron of Spi1, not described before, which was shown tomediate
stage-specific silencer activity dependent on the integrity of
Runx1 and GATA3 binding sites. While GATA3 and Runx1
binding to the previously described CE4 element (Zarnegar
et al., 2010) and a far downstream element at +145 kb may
also contribute, their effects were weaker in a cell line model.
Disruption of the +3.7-kb element alone was sufficient to give
Spi1 at least 50% protection from the repressive effects of
overexpressed GATA3 or Runx1. Thus, the repression of Spi1 by
Runx1 and GATA3 is controlled at least in part via their stage-
specific binding to this Spi1 intronic site.
The striking feature of Runx1 and GATA3 action in repression
of Spi1 has been the stage-specific functional response occurring
with seemingly little change in levels of the two candidate re-
pressive factors. However, both Runx factors and GATA3 have
Figure 5. Activation of Spi1 is induced by deletion of the DN2b/3-specific Runx1 and GATA3 binding site in a DN3-like cell line. (A) A DN3-like cell line,
Scid.adh.2c2, was used for CRISPR-Cas9–mediated deletion of the specific genomic regions around Spi1 locus. First, Scid.adh.2c2 cells were introduced Cas9-
GFP, and then they were infected second retrovirus infection for sgRNAs against two sides of the targeted genomic regions. GFP+CFP+hNGFR+ cells were
subjected to single-cell sorting and expanded for 2 wk. (B) Genomic DNA from each clone was isolated and subjected to qPCR analysis to confirm deletion of
the targeted genomic regions. The relative intensity (/Gapdh promoter) is shown with SD. Data are based on three independent clones. (C) Relative expression
levels of Spi1 against Actb are shown with SD. Circles indicate independent clones. **, P < 0.01; *, P < 0.05 by two-sided Student’s t test. Data are based on
more than five independent clones.
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been noted for the shifting of their genomic binding site choices
from one stage to another in pro–T cells (Hosokawa et al., 2021;
Hosokawa et al., 2018b; Shin et al., 2021; Zhang et al., 2012).
Runx1 protein expression levels increase little between pre-
commitment DN2a and postcommitment DN2b stages (Shin
et al., 2021), and recent data show that Runx3 actually collabo-
rates with Runx1 to repress Spi1 during commitment, with their
combined activities virtually constant before and after Spi1 re-
pression begins (Shin et al., 2021). However, both factors show
the same stage-specific increased binding to the +3.7-kb site
during commitment (Shin et al., 2021). GATA3 protein levels do
increase slightly during commitment, in a way well coordinated
with the change in expression of PU.1, but seemingly by less
than threefold. Thus, despite little absolute change in total Runx
and GATA3, their repression of Spi1 correlates with their occu-
pancy of the +3.7-kb site, possibly connected with a new chro-
matin loop anchored in intron 2. Recruitment could depend on
additional partners not yet defined.
Figure 6. Stage-specific derepression of Spi1 is induced by mutations on the Runx and GATA motifs in the Spi1 +3.7-kb element. (A) The sequence of
the DN2b/3-specific Runx1 and GATA3 binding site at intron 2 of the Spi1 gene (chromosome 2; 91,100,260–91,100,519) is indicated. Runx motifs and a GATA
motif are labeled with green and blue boxes, respectively. Red arrowheads indicate targeted sites for CRISPR-Cas9–mediated direct mutations. (B) sgRNA-
introduced Lin−CD45+CD25+CD44loCFP+hNGFR+ postcommitment cells were sorted and subjected to RT-qPCR analysis at 4 d after sgRNA introduction
(protocol B). The relative expression (/Actb) of Spi1 is shown with SD. **, P < 0.01; *, P < 0.05 by two-sided Student’s t test. Data are representative of two
independent experiments and based on more than five biological replicates. (C) sgControl- or sg4 motifs mix–introduced Lin−CD45+CD25+CD44loCFP+hNGFR+
postcommitment cells were subjected to intracellular staining for PU.1, at 4 d after sgRNA introduction (protocol B). Representative profiles for PU.1
are shown with isotype control staining (gray). Results are representative of four independent experiments. (D) BM progenitors obtained from Cas9;
Bcl2 Tg mice were co-cultured on OP9-DLL1 for 2 d. Precommitment cells were retrovirally introduced with sgRNAs and then analyzed 6 (DN2a/2b
stages) or 12 (DN2b/3 stages) dpi (protocol D). For cell surface phenotypes, see Fig. S5 D. (E) sgRNA-introduced Lin−CD45+CD44+CFP+hNGFR+
DN2a/2b cells (left) and Lin−CD45+CD25+CD44loCFP+hNGFR+ DN2b/3 cells (right) were sorted on 6 or 12 d after sgRNA introduction, respectively, and
subjected to RT-qPCR analysis. The relative expression (/Actb) of Spi1 is shown with SD. **, P < 0.01 by two-sided Student’s t test. Data are representative of
two independent experiments and based on three biological replicates.
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Deletion of Runx1 and Gata3 before T lineage commitment had
stronger effects on progression of pro–T cell development and
Spi1 repression than deletion of the intronic stage-specific Runx1
and GATA3 target site. This could reflect additional repressive
inputs frommore distal regulatory sites, such as the +145-kb site
near the distal end of a new commitment-associated loop, three
to five genes away from the Spi1 locus (Fig. S3 B; and Fig. S4,
B–D). Repressive activity of GATA3 could also be unmasked if it
undergoes signal-dependent dephosphorylation during com-
mitment (Fig. 2 D). Alternatively, as Runx1 and GATA3 are
critical regulators of multiple other genes, their levels could also
influence Spi1 expression via indirect mechanisms (Fig. 7 B). In
principle, they could repress activators of Spi1 such as Cebpa
(Laiosa et al., 2006; Wang et al., 2006; Yeamans et al., 2007) and
Lmo2 (Cleveland et al., 2013). However, Cebpa is expressed at
very low levels in T lineage progenitors, and Lmo2 is turned off
before the DN2a stage, well before Spi1 levels start going down
(Hosokawa and Rothenberg, 2021; Yui and Rothenberg, 2014;
Zhou et al., 2019). Thus, these indirect mechanisms may con-
tribute to, but not fully explain, the stage specificity.
Mutation of the potential repression element enabled Spi1 to
begin expression in a nonexpressing pro–T cell line, under
conditions where deletions of other elements suspected to me-
diate repression had much less effect. Most notably, Cas9 tar-
geting of the three Runx and one GATA motifs in the +3.7-kb
element also enabled primary pro–T cells to sustain readily
measurable Spi1 expression in a developmental stage where
controls had virtually extinguished it. Thus, the integrity of this
element was important for full developmental stage-specific
repression. However, it was atypical of elements normally
sought through genomic methods. The binding of Runx1 and
GATA3, though reproducible under the conditions used, was
very weak. This could reflect the ATAC-inaccessible chromatin
state at this site both before and after commitment. While the
potential silencer region was not conserved among mammals,
this region was perfectly overlapped by a LINE element. LINE
elements are known to acquire roles in species-specific gene
expression via activation and repression of proximal genes
(Robbez-Masson and Rowe, 2015). Furthermore, a recent report
on 3D structure of the human SPI1 locus in monocytes suggest
interactions of the promoter with the intron 2 region of SPI1 as
well as with the URE (Schuetzmann et al., 2018). Hence, stage-
specific repression of human SPI1 could be regulated in part via
similar or independent human-specific elements, even though
the SPI1 locus overall has multiple conserved cis-regulatory
elements.
In summary, we identified a potential stage-specific silencer
region for Spi1, which appears to be controlled by Runx1 and
GATA3, in early T cell development. Acute deletion of Runx1 and
Gata3 by CRISPR-Cas9 revealed stage-specific roles of Runx1 and
GATA3 in Spi1 repression in pro–T cell stages. A postcommit-
ment stage-specific Runx1 and GATA3 occupancy site at the Spi1
locus was elucidated by comparative ChIP-seq analysis using
precommitment and postcommitment pro–T cells, in the same T
lineage pathway but with a few days difference on the trajec-
tory. Acute deletion evidence then supported a strong role for
this site in physiological Spi1 repression. Thus, the develop-
mentally based strategy used in this study could be useful to
identify other functionally important cis-regulatory elements,




C57BL/6 (referred to as B6), B6.Cg-Tg(BCL2)25Wehi/J (Bcl2-Tg;
Strasser et al., 1991), and B6.Gt(ROSA)26Sortm1.1(CAG-cas9*,-EGFP)Fezh/J
(Cas9; Platt et al., 2014) mice were purchased from The Jackson
Laboratory. Bcl11b-YFP (backcrossed to C57BL/6 mice 10
times) mice were described previously (Ng et al., 2018). All
animals were bred and maintained in the California Institute
of Technology Laboratory Animal Facility under specific
pathogen–free conditions, and the protocol supporting animal
breeding for this work was reviewed and approved by the
Institute Animal Care and Use Committee of the California
Institute of Technology.
Cell culture of primary pro–T cells
For in vitro differentiation of pro–T cells, BM hematopoietic
progenitors were used for input to OP9-DLL1 co-cultures
(Schmitt and Zúñiga-Pflücker, 2002). In the conditions used,
most cells underwent commitment around days 6–7 of culture.
Figure 7. Runx1 and GATA3 repress Spi1 expression partly via
the +3.7-kb element of the Spi1 locus. (A) BM progenitors ob-
tained from Cas9;Bcl2 Tg mice were co-cultured on OP9-DLL1.
Precommitment cells were retrovirally introduced with sg4 motifs
mix on day 2, then with Runx1 or Gata3 on day 3. Retrovirus-
transduced cells were analyzed 3 d after the last infection (proto-
col E). (B) Retrovirus-transduced Lin− CD45+ CD44+ CFP+ hNGFR+
GFP+ cells were sorted on 3 d after introduction and subjected to
RT-qPCR analysis as protocol E. The relative expression (/Actb) of
Spi1 is shown with SD. **, P < 0.01; *, P < 0.05 by two-sided Stu-
dent’s t test. Data are representative of two independent experi-
ments and based on three biological replicates.
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Vectors carrying genes for gain of function assays or CRISPR
guide RNAs for knockout assays were introduced at different
time points, depending on whether the cells were to be targeted
before, after, or during commitment. Cells for gain-of-function
experiments were harvested 3 d after transduction, and cells
for loss-of-function experiments were harvested 4 d after
transduction in most cases. The Bcl2 transgene (Tg) was present
in the input cells for all these manipulations because it en-
hances viable recovery of cells under regulatory perturbations,
allowing the RNA and protein expression to be measured in a
more representative fraction of the responding cells, without
altering early T cell development of controls (Yui et al., 2010).
BM was removed from the femurs and tibiae of 2–3-mo-old
mice. Suspensions of BM cells were prepared and stained for
lineage-specific, mature-cell markers (Lin) using the biotin-
conjugated lineage antibodies CD11b (eBioscience; 13–0112-86),
CD11c (13–0114-85), Gr-1 (13–5931-86), TER-119 (13–5921-85),
NK1.1 (13–5941-85), CD19 (13–0193-85), and CD3ε (13–0031-082).
They were then incubated with streptavidin-coated magnetic
beads (Miltenyi Biotec) and passed through a magnetic column
(Miltenyi Biotec) to remove the Lin+ cells. Then, the resulting
enriched hematopoietic progenitors were cultured on OP9-DLL1
monolayers using OP9 medium (α-MEM, 20% FBS, 50 µM
β-mercaptoethanol, and penicillin-streptomycin-glutamine)
supplemented with 10 ng/ml IL-7 (Pepro Tech) and 10 ng/ml
Flt3L (Pepro Tech). On day 7, cultured cells were disaggregated,
filtered through 40-µm nylon mesh, and recultured on new
OP9 monolayers with medium containing 5 ng/ml IL-7 and
5 ng/ml Flt3L. In cultures that were continued for longer times,
cells were passaged onto fresh OP9-DLL1 monolayers at day 10
and maintained up to day 14 in 1 ng/ml each of IL-7 and Flt3L.
While the developmental trajectory of the cells in these cul-
tures is extremely reproducible between experiments and ex-
perimenters, the exact degrees of progression of the cells along
the pathway at a given time point often vary slightly from ex-
periment to experiment. For precise measurements of fold
change, to establish biological reproducibility with minimum
confounding effects of timing on the expression of highly dy-
namic genes, biological replicate cell samples were prepared
separately from three independent animals, purified separately,
vector transduced separately, and cultured separately, but in
parallel over the same absolute time course. Additional sup-
porting information was obtained in independent experiments.
Cell culture of a pro–T cell-like line
Scid.adh.2c2 cells (Dionne et al., 2005) were cultured in
RPMI1640 with 10% FBS (Sigma-Aldrich), sodium pyruvate
(Gibco), nonessential amino acids (Gibco), penicillin-strepto-
mycin-glutamine (Gibco), and 50 µM β-mercaptoethanol
(Sigma-Aldrich).
Transduction of Runx1 and Gata3 into pro–T cells
Gain-of-function experiments were performed before commit-
ment using protocol A (Fig. 2 A). BM progenitor cells from Bcl2-
Tg animals were used to seed in vitro differentiation cultures as
above. At day 3, the cells were transduced with retroviral vec-
tors encoding reporters (GFP and hNGFR) and the indicated
cDNAs (details of vector construction below) and then returned
to OP9-DLL1 culture for harvest on day 6 overall. A modification
of this protocol was used for gain of function of Runx1 and
GATA3 coupled with disruption of the +3.7-kb site motifs as
detailed in Fig. 7 A (protocol E). Conditions for Cas9-mediated
disruption are described in the next section. The methods used
to generate the virus supernatant and for infection were de-
scribed previously (Hosokawa et al., 2018a). For RT-qPCR analysis,
retrovirus-infected Lin−CD45+CD44+GFP+hNGFR+ (precommitment)
cells were sorted on a BD FACSAria.
CRISPR-Cas9–mediated acute deletion of target genes in
primary cells and a cell line
Acute deletions of Gata3 or Runx1 or their presumptive target
sites in primary cells were performed using protocols B, C
(Fig. 3, A and D), D, or E (Figs. 6 D and 7 A) to induce deletion in
postcommitment, mid-commitment, or precommitment stages,
respectively. To generate input cells, Cas9 mice were first bred
to Bcl2-Tg mice to generate heterozygotes for both transgenes.
BM cells from these Cas9;Bcl2-Tg animals were then used to seed
in vitro differentiation cultures as above. At day 10 (for post-
commitment effects, protocol B), day 4 (for mid-commitment
effects, protocol C), or day 2 (for precommitment effects, pro-
tocol D), the cells were transduced with retroviral vectors en-
coding reporters (GFP, CFP and hNGFR) and the indicated
cDNAs or guide RNAs (sgRNAs) as detailed below, and then
returned to OP9-DLL1 culture for harvest 4 d later, at day 14
overall (protocol B), day 8 overall (protocol C), or day 6 overall
(half of the cultures in protocol D). The other half of the cultures
treated early, via protocol D, were continued to day 12 overall to
monitor postcommitment effects of precommitment deletion.
The methods used to generate the virus supernatant and for
infection were as described previously (Hosokawa et al., 2018a).
For RT-qPCR analysis, retrovirus-infected Lin− CD45+ CD44+
GFP+ hNGFR+ (precommitment) or Lin− CD45+ CD44lo CFP+
hNGFR+ (postcommitment) cells were sorted on a BD FACSAria.
A DN3-like cell line, Scid.adh.2c2, previously transduced to
express Cas9-GFP, was infected with sgRNA-hNGFR and/or
sgRNA-CFP vectors (Hosokawa et al., 2018b). 3 d after sgRNA
transduction, sgRNA-introduced GFP+CFP+hNGFR+ Scid.adh.2c2
cells were sorted, followed by immunoblotting, or subjected to
single-cell sorting. Cytoplasmic and nuclear extracts, used to the
detection of tubulinα, and Runx1 and GATA3, respectively, were
prepared using NE-PER nuclear and cytoplasmic extraction re-
agents (Pierce). Lysates were run on 10% polyacrylamide gel,
followed by immunoblotting. The antibodies used for the im-
munoblot analysis were anti-tubulinα (Sigma-Aldrich; T6199),
anti-Runx1 (Abcam), anti-Myc (MBL; My3), and anti-GATA3
(Santa Cruz Biotechnology; HG3-31) mAbs.
Cloning
cDNAs for GATA3 WT and mutants were inserted into a mul-
ticloning site of the pMxs-IRES-hNGFR, as previously reported
(Hosokawa et al., 2015; Hosokawa et al., 2016).
GATA3 residues S308, T315 and S316, which are important
for histone deacetylase 2 association in their nonphosphorylated
state, are near the C-terminal zinc finger (Hosokawa et al., 2016;
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Hosokawa et al., 2013b). GATA3 R261, where arginine methyl-
ation increases transcriptional activation potency, is near the
N-terminal zinc finger.
cDNA for full-length Runx1 from the distal promoter and
Runx1DN (Runx1 d190) were inserted into a multicloning site of
the MSCV-IRES-GFP (Telfer et al., 2004). For CRISPR targeting,
the sgRNA-expression vector (E42-dTet; Hosokawa et al., 2018b)
was used as described previously. For double-KO experiments,
versions of E42-dTet with truncated NGFR reporter were made
as well the original vector with a CFP reporter (here, mTur-
quoise2) so that doubly transduced cells could be sorted unam-
biguously. For site disruption experiments, vectors for sgRNA
against Runx motifs were made with an hNGFR reporter,
whereas vectors for sgRNA against the GATA motif were made
with a CFP reporter. 19- or 20-mer sgRNAs were designed using
the CHOPCHOP (https://chopchop.cbu.uib.no; Labun et al.,
2016) or Benchling (https://benchling.com) web tool and in-
serted into the empty sgRNA-expression vector by PCR-based
insertion. Three sgRNA-expression vectors were generated for
one gene, and pooled retroviral plasmids were used to make
retroviral supernatant. The following sgRNA sequences were
used in this study: control (Luciferase), 59-GGCATTTCGCAGCCT
ACCG-39; GATA3 #1, 59-GAGATCCGTGCAGCAGAGG-39; GATA3
#2, 59-GTTCCAGGGCGAGGCGGTG-39; GATA3 #3, 59-TGGCCG
GCCGCCAGAGAAG-39; Runx1 #1, 59-GCTCGTGCTGGCATCTAC
G-39; Runx1 #2, 59-AGCCCCGGCAAGATGAGCG-39; Runx1 #3, 59-
AGCGGCGACCGCAGCATGG-39; Slc39a13 pro. #1, 59-GCAGAT
GCAGCGCTCCGGG-39; Slc39a13 pro. #2, 59-AGGGTTACAGTC
CTGGAGA-39; URE #1, 59-CAAATGGCCCGAGGTCCGA-39; URE
#2, 59-TACGATCTAGACAGTGGGT-39; CE4 #1, 59-TAGAGCTGA
GCCTAAGTTC-39; CE4 #2, 59-CTGAGGAAGACTTCCAGGT-39;
Spi1 intron2 #1, 59-CCTGTAATCCTCTCTCGGG-39; Spi1 intron2
#2, 59-CACGTGGACCAGAGGTCAC-39; +145 kb #1, 59-GGTGTA
AGAAGCAGAGTCTG-39; +145 kb #2, 59-TTTGTTCACACTGGA
AACTG-39; +167 kb #1, 59-GCCTACAGCCAGTGGTCGAG-39; +167
#2, 59-GGTACGGGTCCTGACGCCGG-39; +211 #1, 59-AGAAAGATT
CCAATTCAACA-39; +211 #2, 59-TCTACTAGGTCTTACCAACT-39;
Runx motif 1, 59-GATGAACTCAGTGTGGTTT-39; Runx motif 2,
59-CTCGACCTGCCCTTAAATG-39; Runx motif 3, 59-AAACTA
ATCTTTTCTCTGT-39; and GATAmotif, 59-CTCTGTGGGTGCTTA
TCAC-39.
Two-step affinity purification of GATA3 complexes from
Scid.adh.2c2 cells
Scid.adh.2c2 cells were infected with either mock control
(pMxs-IRES-GFP) or Myc-Flag-GATA3–containing retrovirus. 3
dpi, Myc-Flag–tagged GATA3-infected GFP+ cells were solubi-
lized with the following protease inhibitor–containing immu-
noprecipitation buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl,
10% glycerol, 0.1% Tween, 1 mM EDTA, 10 mM NaF, 1 mM DTT,
and a protease inhibitor cocktail (Roche Applied Science) and
lysed on ice for 30 min with gentle shaking and sonicated on a
Misonix S-4000 sonicator (Qsonica) for three cycles, amplitude
20 for 30 s, followed by a 30-s rest. The insoluble materials were
removed by centrifugation, and immunoprecipitation with anti-
Flag M2 agarose (Sigma-Aldrich) was performed overnight at
4°C. Immune complexes were eluted from the agarose by 3xFlag
peptide (Sigma-Aldrich), and the eluted GATA3 complexes were
subjected to a second immunoprecipitation with anti-Myc gel
(MBL). Immune complexes were eluted from the gel with Myc
peptide (MBL) and separated by SDS-PAGE. The bands were
excised from the gel and subjected to a mass spectrometric
analysis to identify corresponding proteins. The gel pieces were
washed twice with 100 mM bicarbonate in acetonitrile, and the
proteins were digested with trypsin. After adding 0.1% formic
acid to the supernatant, the peptides were analyzed by liquid
chromatography-tandem mass spectrometry with an Advance
ultra-high-performance liquid chromatograph (Bruker) and an
Orbitrap Velos Pro mass spectrometer (Thermo Fisher Scien-
tific). The resulting tandem mass spectrometry dataset was an-
alyzed using the Mascot software program (Matrix Science).
Mascot score is the probability that the observed match is a
random event (Mascot score >100 means the absolute proba-
bility <1e-10).
Flow cytometry analysis
Thymocytes were isolated from 4–6-wk-old Bcl11b-YFP reporter
mice. Lin+ cells were depleted by staining with biotinylated
antibodies against CD8α (eBioscience; 13–0081-86), TCRγδ
(13–5711-85), TCRβ (13–5961-85), TER-119, NK1.1, Dx5 (13–5971-
82), CD11c, and CD11b, then incubating cells with streptavidin
magnetic beads, followed by passing them through an LS mag-
netic column (Miltenyi Biotec) in accordance with the manu-
facturer’s instructions. Purified DN cells were stained with c-Kit
APCe780 (eBioscience; 17–1171-82), CD25 PE (12–0251-28), CD44
e450 (48–0441-82), and streptavidin PerCPCy5.5 (45–4317-80)
and then subjected to intracellular staining for GATA3 AF647
(BD PharMingen; 560068) or PU.1 AF647 (Cell Signaling; 2240)
using the BrdU Flow Kit (BD PharMingen).
For staining of sgRNA-introduced BM cells, surface anti-
bodies against CD45 PECy7 (eBioscience; 25–0451-82), c-Kit APC,
CD25 APC-e780 (47–0251-82), human-NGFR PE (12–9400-42),
and a biotin-conjugated lineage cocktail (CD8α, CD11b, CD11c,
Gr-1, TER-119, NK1.1, CD19, TCRβ, and TCRγδ) with streptavidin
PerCPCy5.5 were used for staining.
Prior to cell surface staining, cells were treated with 2.4G2
cell supernatant. All of the cells were analyzed using flow cy-
tometers, MacsQuant 10 (Miltenyi Biotec), LSRFortessa (BD
PharMingen), or FACSAria (BD PharMingen) with FlowJo
software (Tree Star).
ChIP library construction and characteristics
ChIP experiments and library preparation were performed as
previously described (Hosokawa et al., 2018b; Ungerbäck et al.,
2018). Briefly, 5–10 × 106 cells were fixed with 1 mg/ml DSG
(Thermo Fisher Scientific) in PBS for 30 min at room temper-
ature followed by an additional 10 min with addition of form-
aldehyde up to 1%. These conditions were previously found to
give efficient detection of Runx1 binding with strong enrich-
ment for Runx target motifs (Hosokawa et al., 2020; Hosokawa
et al., 2018b). 5 μg anti-GATA3 mAbs (a mixture of 2.5 µg sc-268
[Santa Cruz Biotechnology] and 2.5 µg MAB26051 [R&D Sys-
tems]) or anti-Runx1 mAb (Abcam; ab23980) was prebound to
Dynabeads anti-Mouse or anti-Rabbit Ig (Invitrogen) and then
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added to the diluted chromatin complexes. Precipitated chro-
matin fragments were cleaned up using Zymo ChIP DNA Clean
& Concentrator and used as input for qPCR and/or ChIP-seq.
Note that GATA3 shows highly conditional genomic binding
patterns at different stages within the T cell lineage, suggesting
influence from factors other than its binding affinities for dif-
ferent genomic sequences (Wei et al., 2011; Zhang et al., 2012).
For comparison in Fig. S3 A, a separate pair of DN2b/DN3
samples was also prepared for GATA3 ChIP-seq using fixation
with 1% formaldehyde only for 10 min, as described previously
(Ungerbäck et al., 2018). The patterns of GATA3 occupancy de-
tected depended on the fixation used. GATA3 associations with
many enhancer-like sites near suspected positive target genes
were consistent, but GATA3 association with closed regions,
promoters, and repeat sequence elements appeared systemati-
cally different between the two fixation conditions (compare
with Fig. S3 A), with characteristics summarized in Fig. S5 F.
Briefly, DSG+FA showed higher association with promoters and
ATAC-open sites, whereas FA alone showed higher enrichment
for strong GATA binding motifs but a substantially higher pro-
portion of binding to repeat sequences. Thus, different fixation
conditions could selectively stabilize interactions with different
binding-modulatory chromatin contexts. Admixtures of func-
tional sites with different “background” sequences are expected
to alter relative enrichment, a key consideration for global sta-
tistical comparisons. However, in this study, the goal was
maximal absolute recovery of candidates for functionally im-
portant sites within the Spi1 genomic neighborhood to maxi-
mize the chance for relevant repression sites to be detected.
Quantitative ChIP-PCR and ChIP-seq
For qPCR analysis, 7900HT Fast Real-time PCR System, Quant-
Studio3 (Applied Biosystems) or StepOnePlus systems (Applied
Biosystems) were used with SYBR GreenER qPCR SuperMix
(Invitrogen). The data are shown as the mean values (percent
input). Primers are listed below. For deep-sequencing analysis,
ChIP-seq libraries were constructed using NEBNext ChIP-Seq
Library Preparation Kit (E6240, NEB) and sequenced on Illu-
mina HiSeq2500 in single read mode with the read length of
50 nt. All analyses are based on results from two biologically sep-
arate replicates. ChIP-seq data were analyzed as described previ-
ously (Hosokawa et al., 2018b; Ungerbäck et al., 2018). BigWigs
were generated from the aligned SAM or BED-file formats using
Samtools (Li et al., 2009), Bedtools (Quinlan and Hall, 2010) and
the UCSC genomeCoverageBed and bedGraphToBigWig and
normalized to 1 million reads. For visualization of ChIP-seq
tracks, bamToBed and genomeCoverageBed were used with the
“-split” setting enabled. BigWig files were up-loaded to the
UCSC genome browser (http://genome.ucsc.edu; Speir et al.,
2016). Runx1 ChIP-seq data in DN1 and DN2b/3 cells and
Runx1 and GATA3 ChIP-seq data in Scid.adh.2c2 cells used in
this study were previously published (GEO accession numbers
GSE103953 and GSE93755; Hosokawa et al., 2018b): Slc39a13 pro.
forward (FW), 59-CCTTCTGAGGATGCAGTTCC-39; Slc39a13 pro.
reverse (RV), 59-CTGCTGACTCAGAGAGCCATAG-39; URE FW,
59-GGGCGCTTCCTGTTTTCT-39; URE RV, 59-CTGGGCAGGGTC
AGAGTG-39; CE4 FW, 59-TTTGAGGTGCAGGAGACTGA-39; CE4
RV, 59-TGAATCTTACTGAACCCCGTCT-39; intron 2 FW, 59-CTC
GACCTGCCCTTAAATGT-39; and intron 2 RV, 59-CCAGTGATA
AGCACCCACAG-39.
qPCR
Total RNA was isolated from samples of 2 × 105 cultured cells
using a RNeasy Micro Kit (Qiagen). Reverse transcription was
performed using the Superscript III kit (Invitrogen). Genomic
DNA was isolated from 5 × 105 cultured cells using a NucleoSpin
Tissue kit (Macherey-Nagel). For qPCR, the 7900HT Fast Real-
time PCR System, QuantStudio3 (Applied Biosystems), or Ste-
pOnePlus system (Applied Biosystems) were used with SYBR
GreenER qPCR SuperMix (Invitrogen). The data are shown as
the relative expression normalized to Actb (for cDNA) or Gapdh
promoter (genomic DNA) signals. The following primers were
used in this study: PU.1 FW, 59-TTCTGCACGGGGAGACAG-39;
PU.1 RV, 59-GTCCACCCACCAGATGCT-39; GATA3 FW, 59-TAT
CCTCCGACCCACCAC-39; GATA3 RV, 59-AAGGGGCTGAGGTTC
CAG-39; Runx1 FW, 59-CTCCGTGCTACCCACTCACT-39; Runx1
RV, 59-ATGACGGTGACCAGAGTGC-39; Actb FW, TACAGCCCG
GGGAGCAT-39; Actb RV, 59-ACACCCGCCACCAGTTC-39; Bcl11b
FW, 59-TGGATGCCAGTGTGAGTTGT-39; Bcl11b RV, 59-GCTGCT
TGCATGTTGTGC-39; Slc39a13 pro. FW, 59-CCTTCTGAGGATGCA
GTTCC-39; Slc39a13 pro. RV, 59-CTGCTGACTCAGAGAGCCATA
G-39; URE FW, 59-GGGCGCTTCCTGTTTTCT-39; URE RV, CTG
GGCAGGGTCAGAGTG-39; CE4 FW, 59-TTTGAGGTGCAGGAG
ACTGA-39; 59-CE4 RV, TGAATCTTACTGAACCCCGTCT-39; in-
tron 2 FW, 59-CTCGACCTGCCCTTAAATGT-39; intron 2 RV, 59-
CCAGTGATAAGCACCCACAG-39; +145 kb FW, 59-GGCACCTTT
AACCCAGAGTTC-39; +145 kb RV, 59-AATGAATGACATCAGGCT
ACCA-39; +167 kb FW, 59-GAAGTTTGGGCCAGTCCAC-39; +167 kb
RV, 59-TCTGGGCCAATGAACGTC-39; +211 kb FW, 59-CTGTAA
ACAGGAAACACTCAGCTC-39; +211 kb RV, 59-GTGGATGGCTTG
CAGTAGG-39; Ddb2 FW, 59-TTGGCATCAAGGACAAACCT-39;
Ddb2 RV, 59-AAACTGGTTGGTATTGAGATGGTT-39; Pacsin3 FW,
59-GAAGGCAGACAGCTCCATGT-39; and Pacsin3 RV, 59-GGGTCT
GCTCATACTGGGTTT-39.
Statistical analysis
The statistical significance of differences between datasets was
determined by two-sided Student’s t test using Excel. Statistical
details of experiments can be found in the figure legends. In all
figures, error bars indicate SD.
Online supplemental material
Fig. S1 shows gating strategies for DN subsets in thymocytes and
in vitro–differentiated pro–T cells, Spi1 expression levels in
Bcl11b introduced pro–T cells, the ratio of sense and antisense
Spi1 transcripts, proteomics data for GATA3-interacting mole-
cules, and interactions between Runx1 and GATA3 mutants. Fig.
S2 shows evidence for successful Runx1 and GATA3 disruption
by Cas9 and gating strategies for DN subsets from in vitro–
differentiated pro–T cells. Fig. S3 shows a comparison of GATA3
binding sites in different fixation conditions, a comparison of
chromatin looping before and after T lineage commitment
around the Spi1 locus, and a comparison of Runx1 and GATA3
binding patterns in phase 1, phase 2, and a DN3-like cell line. Fig.
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S4 shows a comparison of Runx1 and GATA3 binding patterns in
GATA3- or Runx1-deficient pro–T cells around the Spi1 locus,
Runx1 and GATA3 binding patterns around the postcommitment
stage-specific distal chromatin looping sites, and Spi1 expression
levels in +145, +167, or +211 kb element–disrupted DN3-like cell
lines. Fig. S5 shows representative consensus motifs for Runx1
and GATA3, gating strategies for DN subsets in BM-derived
pro–T cells with motif disruptions, validation of mutations in
sg4 motifs mix-transduced pro–T cells, Spi1 expression levels in
the cis-regulatory element disrupted cells, and a table comparing
GATA3 occupancy site characteristics under different fixation
conditions. Table S1 lists GATA3-interacting molecules in a
pro–T cell-like cell line, Scid.adh.2c2.
Data availability
The GEO accession number for all new deep-sequencing data
reported in this paper is GSE159960.
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Figure S1. Effects of Runx1, GATA3, or Bcl11b introduction on Spi1 expression in precommitment pro–T stages. (A) Flow cytometric analysis of
thymocytes from Bcl11b-YFP reporter mice was performed. Representative Kit/CD44 profile in Lin− cells (top) and CD25/Kit profile in Lin−KithiCD44hi
cells (bottom) are shown. Results are representative of three independent experiments. (B) Flow cytometric analysis of retrovirus-infected
Lin−CD45+CD44+GFP+hNGFR+ precommitment cells was performed at 3 d after introduction using protocol A. Gating strategy for Lin−CD45+GFP+hNGFR+
cells is shown (top). Representative profiles of CD44/CD25 in Lin−CD45+GFP+hNGFR+ cells are shown (bottom). Gates to isolate CD44+ cells for sorting are
labeled with red rectangles. Results are representative of three independent experiments. (C) Retrovirus encoding Bcl11bwas infected into precommitment cells,
and then Lin−CD45+CD44+GFP+hNGFR+ cells were sorted at 3 d after introduction from protocol A. Expression levels of Spi1 and Bcl11b were analyzed by RT-
qPCR. The relative expression (/Actb) is shown with SD. *, P < 0.05; **, P < 0.01 by two-sided Student’s t test. Data are based on three biological replicates. (D)
Retrovirus-infected Lin−CD45+CD44+GFP+hNGFR+ precommitment cells were sorted at 3 d after introduction (protocol A). Strand-specific cDNAs around the
exon 3 region of the Spi1 locus were synthesized as described previously (Ebralidze et al., 2008). Ratio of antisense transcripts against sense transcripts
(antisense/sense) of Spi1 exon3 is shown with SD. Data are based on three biological replicates. (E)Myc- and Flag-tagged (double epitope–tagged) GATA3 was
retrovirally transduced into a DN3-like cell line, Scid.adh.2c2. Total extracts from Myc-Flag-GATA3–expressing Scid.adh.2c2 cells were subjected to two-step
affinity purification followed by SDS-PAGE and silver staining. All of the visible bands were subjected to mass spectrometry analysis. Data are representative of
two independent experiments. (F) Gene Ontology (GO) annotation of proteins identified from their GATA3-interacting peptides was performed using the DAVID
analysis tool (http://david.ncifcrf.gov/). Top three GO terms for GATA3-interacting molecules (Table S1) are shown. (G) Total extracts from Scid.adh.2c2 cells
transduced with Myc-Flag-GATA3 WT, -3A, or -3D were subjected to immunoprecipitation (IP) with anti-Flag mAb followed by immunoblotting (IB) with anti-
Runx1 antibodies. To measure protein levels in the inputs, nuclear or cytoplasmic lysates were subjected to IB with anti-Myc (GATA3), anti-Runx1, or anti-
tubulinα antibodies, respectively (input). Data are representative of three independent experiments.
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Figure S2. Effects of Runx1 or GATA3 perturbations on Spi1 expression in postcommitment pro–T stages. (A) To test Cas9-mediated disruption,
Scid.adh.2c2 cells already expressing Cas9 from a GFP+ vector were transduced with sgRunx1 or control in an hNGFR+ vector or with sgGata3 or control in a
CFP+ vector. 3 d after sgRNA transduction, lysates from the retrovirus-infected Cas9-GFP+CFP+ or Cas9-GFP+hNGFR+ Scid.adh.2c2 cells were subjected to
immunoblotting (IB) for Runx1 (top) and GATA3 (bottom), respectively. Two independent experiments were performedwith similar results. (B) Flow cytometric
analyses of retrovirus-infected Lin−CD45+CFP+hNGFR+ postcommitment primary cells were performed at 4 d after transduction using protocol B. Gating
strategies for Lin−CD45+GFP+hNGFR+ cells are shown (top). Representative profiles of CD44/CD25 in Lin−CD45+GFP+hNGFR+ cells are shown (bottom). Gates
to define CD44lo cells for sorting are labeled with red rectangles. Results are representative of three independent experiments. (C) Lin−CD45+CFP+hNGFR+
cells that had been transduced with sgRNAs before commitment were subjected to flow cytometric analysis at 4 d after transduction using protocol C. Gating
strategies for Lin−CD45+GFP+hNGFR+ cells are shown (top). Representative profiles of CD44/CD25 in Lin−CD45+GFP+hNGFR+ cells are shown (bottom). CD25+
cells for sorting were labeled with red rectangles. The percentages of CD25+CD44lo cells are indicated with SD. **, P < 0.01 by two-sided Student’s t test for the
indicated sample pairs. Data are representative of two independent experiments and based on three biological replicates in an experiment.
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Figure S3. GATA3 and Runx1 modestly bind to the intronic region of the Spi1 locus in DN2b/3 and Scid.adh.2c2 cells. (A) Sensitivity of GATA3 DNA-
binding pattern to ChIP-seq cross-linking conditions. FA+DSG-cross-linked DN1 and DN2b/3 cells and FA cross-linked DN2b/3 cells were subjected to ChIP-seq
analysis for GATA3. ChIP-seq tracks around the Spi1 locus are shown with representative ATAC-sequencing tracks in long-term hematopoietic stem cells (LT-
HSC), short-term (ST-) HSC, DN1, DN2a, DN2b, DN3, and double-positive (DP) cells (Yoshida et al., 2019) and the conservation track. The Spi1 locus is
highlighted in light blue. (B) Changes in higher-order chromatin looping around the Spi1 locus before and after pro–T cell commitment, from published Hi-C
results of (Hu et al., 2018). Map positions are in mm9 coordinates (top) and therefore show some offset from mm10 coordinates in other figure panels. Gene
models are at bottom (RefSeq genes). Tracks for A/B compartment flip and change in domain score are empty due to lack of changes in this genomic region.
Active transcription units are indicated by “RNASeq DN2” track, and strongly open chromatin is shown by DNase sequencing from DN2 cells in the study. Arc
plots pool data from hematopoietic stem cells to DN2 cells as “precommitment” due to the constancy of their patterns, and data from DN3 to double positive as
“postcommitment”. Arcs shown are those that connect any promoters to any DNase-sensitive region. Data display was downloaded from the Washington
University St. Louis epigenome browser (http://epigenomegateway.wustl.edu/browser/?genome=mm9&session=bxT0F5m0YY). New arcs appearing during
commitment that involve the Spi1 locus are indicated by arrows, and their anchor points in the Spi1 locus or the Spi1-Slc39a13 intergenic region (site of the URE)
are indicated by blue stars. Dark blue star indicates the intron 2 anchor point. (C) DN1, DN2b/3, and Scid.adh.2c2 cells were subjected to ChIP-seq analysis for
Runx1 and GATA3 (GSE103953 and GSE93755; Hosokawa et al., 2018b). ChIP-seq tracks around the Spi1 locus are shown. Previously reported cis-regulatory
elements and a DN2b/3-specific Runx1 and GATA3 binding site are labeled with blue and magenta rectangles, respectively.
Hosokawa et al. Journal of Experimental Medicine S4








f Technology user on 28 June 2021
Figure S4. Potential silencer activity of the DN2b/3-specific looping site around the Spi1 locus. (A) Test for interdependence of GATA3 and Runx1
binding to candidate Spi1 regulatory elements. sgRNA-introduced Lin−CD45+hNGFR+CFP+ postcommitment cells were purified using protocol B, and then the
binding of Runx1 and GATA3 at the previously reported cis-regulatory elements and the DN2b/3-specific Runx1 and GATA3 binding site around the Spi1 locus
were determined by ChIP assay with qPCR analysis. The mean values (percent input) are shown with SD. Data are based on two independent experiments.
UTR, untranslated region. (B) Representative ChIP-seq tracks in DN1 and DN2b/3 cells and ATAC-sequencing tracks in DN1, DN2a, DN2b, and DN3 cells are
shown with the conservation track over an extended region around the Spi1 locus. Runx1 and GATA3 binding sites around the DN2b/3-specific looping site
(+145, +167, and +211 kb) are labeled with magenta rectangles. Data are representative of two independent experiments. (C) Efficient disruption of candidate
distal regulatory elements. Cas9-introduced Scid.adh.2c2 cells were infected with sgRNAs against two sides of the targeted genomic regions (+145-, +167-, and
+211-kb sites in B). GFP+CFP+hNGFR+ cells were subjected to single-cell sorting and then expanded for 2 wk, as in Fig. 5 A. Genomic DNA from each clone was
isolated and subjected to qPCR analysis to confirm deletion of the targeted genomic regions. The relative intensity (/Gapdh promoter) is shown with SD. Data
are based on five independent clones from each sgRNA transduction. (D) Relative expression levels of Spi1, against Actb, are shown with SD. Circles indicate
independent clones. **, P < 0.01 by two-sided Student’s t test. Data are based on five independent clones.
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Table S1 is provided online as a separate Excel file and lists GATA3-interacting molecules in a pro–T cell-like cell line, Scid.adh.2c2.
Figure S5. Effects of mutations of the Runx and GATA motifs in the Spi1 +3.7-kb element in primary pro–T cells. (A) Runx1 (top) and GATA3 (bottom)
motif sequence logos from JASPAR reference motif are shown. (B) Flow cytometric analyses of sgRNA-introduced Lin−CD45+CFP+hNGFR+ cells were per-
formed as protocol B. Representative CD44/CD25 profiles are shown, with magenta rectangles indicating sorting gates. Results are representative of three
independent experiments. (C) Mutation types induced in the +3.7-kb element by Cas9-mediated disruption using the sg4 motifs mix. Genomic DNA samples
from the sgControl (sgCont.) or sg4 motifs mix–introduced Lin−CD45+CFP+hNGFR+ cells (B) were subjected to PCR analysis using FW and RV primers (indicated
with arrows). The gel of PCR amplicons shows that different cells in the population experienced different extents of deletions. Each band was TA-cloned and
sequenced and all were found to be altered from WT. Summary of mutations found in cells transduced with the sg4 motifs mix is shown. (D) Flow cytometric
analyses of sgRNA-introduced Lin−CD45+CFP+hNGFR+ cells were performed using protocol D. Representative CD44/CD25 profiles 6 (left) or 12 (right) d after
sgRNA infection are shown. CD25+ (6 d) and CD44lo (12 d) cells for sorting were labeled with red rectangles. Results are representative of three independent
experiments. (E) sgRNA-introduced Lin−CD45+CD44+CFP+hNGFR+ DN2a/2b cells and Lin−CD45+CD25+CD44loCFP+hNGFR+ DN2b/3 cells were subjected to
RT-qPCR analysis as protocol D. The relative expression levels (/Actb) of Spi1 are shown with SD. **, P < 0.01 by two-sided Student’s t test. Data are rep-
resentative of two independent experiments and based on three biological replicates within an experiment. (F) Characterization of the GATA3 ChIP-seq peaks
detected under different conditions of cross-linking. Percentages of GATA3 ChIP peaks from FA or DSG+FA (see Materials and methods) cross-linked DN2b/3
cells on promoters, ATAC-open regions, and repeat sequence elements and P values for enrichment of GATA motif are shown.
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